Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ottawa Hospital Research Institute
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Newly diagnosed invasive breast cancer (stage I-III) scheduled to receive neo/adjuvant anthracycline/cyclophosphamide or platinum-based chemotherapy
≥18 years
Able to provide consent and complete all study-related diaries and questionnaires.
You may not be if
Received previous chemotherapy
Symptoms of nausea or vomiting at baseline
On chronic antiemetic therapy (e.g. metoclopramide); on daily long term oral steroids prior to chemotherapy
Allergic or having a medical condition that makes the administration of olanzapine, aprepitant, 5-HT3 antagonists or dexamethasone contraindicated
Uncontrolled diabetes
Known/documented medical/psychiatric illness that would interfere with patients' ability to complete the diary and study-related questionnaires.
Clareo Health | Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study
